New research is helping shed light on the ways chronic inducible cold urticaria (ColdU) can affect the daily lives of ...
Measuring treatment success in Sjögren's disease requires more than tracking systemic disease activity alone. Fatigue, pain, ...
More than half a million patients in the UK have inflammatory bowel disease (IBD), and research suggests that up to 30% ...
A newly released independent research review is contributing fresh scientific perspective to the ongoing discussion around ...
A recent study reveals comparable outcomes for radical cystectomy and bladder-sparing therapy in treating recurrent ...
Analysis of the phase 3 explorer7 (NCT04083781) study indicates a preference for concizumab prophylaxis over no prophylaxis in patients with hemophilia A or B with inhibitors. Among individuals with ...
When patients provide information about how they are doing, including symptoms, functionality, and quality of life, scientists can use this data, called patient-reported outcomes (PROs), to conduct ...
Patients report less pain, better mobility, and 1,500+ lbs lost. I feel great! My husband and I went shopping the other day for the first time in a long time—with no cane or walker.” — Anita Worley ...
Efficacy and Safety of Disitamab Vedotin in Patients With Human Epidermal Growth Factor Receptor 2–Positive Locally Advanced or Metastatic Urothelial Carcinoma: A Combined Analysis of Two Phase II ...
Forbes contributors publish independent expert analyses and insights. Michael L. Millenson writes about healthcare as a skeptical optimist. An unusual study gives a new twist to the idea of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback